Reported Earlier: Vera Therapeutics To Present Phase 3 Atacicept Data For IgAN In Featured Late-Breaking Session At ASN Kidney Week 2025

Vera Therapeutics, Inc. Class A +0.67% Post

Vera Therapeutics, Inc. Class A

VERA

40.50

40.50

+0.67%

0.00% Post

Vera Therapeutics, Inc. (NASDAQ:VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that data from the ORIGIN Phase 3 clinical trial of atacicept for the treatment of IgA nephropathy (IgAN) will be delivered as a featured late-breaking oral presentation during the opening plenary session of the American Society of Nephrology (ASN) Kidney Week 2025 in Houston, Texas, being held November 6 to 9. In addition, two informational posters will describe the ORIGIN Extend and PIONEER trials of atacicept in IgAN and other autoimmune mediated glomerular diseases.

ASN Kidney Week 2025 Presentation Details

Title: ORIGIN 3: A Phase 3 Trial of Atacicept in IgAN
Presenting Author: Richard Lafayette, MD, FACP, Professor of Medicine (Nephrology) and Director of the Glomerular Disease Center at Stanford University Medical Center
Abstract Number: TH-OR083
Session Title: Opening Plenary: Featured High-Impact Clinical Trials
Session Date, Time: Thursday, November 6, 2025 from 9:02 AM to 9:14 AM CST
Location: Hall A, Convention Center
Title: ORIGIN Extend: A Long-Term Extension Study of Atacicept in IgAN
Presenting Author: Richard Lafayette, MD, FACP, Professor of Medicine (Nephrology) and Director of the Glomerular Disease Center at Stanford University Medical Center
Poster Board Number: INFO12-TH
Session Date, Time: Thursday, November 6, 2025 from 10:00 AM to 12:00 PM CST
Location: Exhibit Hall, Convention Center
Title: PIONEER: A Basket Trial of Atacicept in Autoimmune Mediated Glomerular Disease
Presenting Author: Richard Lafayette, MD, FACP, Professor of Medicine (Nephrology) and Director of the Glomerular Disease Center at Stanford University Medical Center
Poster Board Number: INFO13-TH
Session Date, Time: Thursday, November 6, 2025 from 10:00 AM to 12:00 PM CST
Location: Exhibit Hall, Convention Center
This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.